For citations:

New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer). Rational Pharmacotherapy in Cardiology. 2016;12(4):487-488. (In Russ.)